Exact(5)
There was no significant difference in time duration from onset to corticosteroids therapy between the death and the surviving groups (p=0.44).
There was a significant difference on how soon to be admitted between the death and the surviving groups (OR 0.09, 95% CI 0.01 to 0.68).
No significant difference appeared between the death and the surviving groups in the median of time duration for antiviral treatment (p=0.32).
There was no significant difference of time duration from onset to antiviral treatment between the death and the surviving groups (OR 0.95, 95% CI 0.21 to 4.30), and the median was 5 days either in the death group or in the surviving group.
One (4%) death case and 11 (41%) surviving cases took corticosteroids within 3 days after the onset, and there was no significant difference in time duration from onset to corticosteroids therapy between the death and the surviving groups (OR 0.25, 95% CI 0.03 to 1.86).
Similar(55)
The pregnant women with p(H1N1) infection showed no significant difference in age between the death group and the surviving group and the median age in two groups was 21 years.
In terms of corticosteroids therapy, no significant difference was seen between the death group and the surviving group either in how soon or how long to use it so may be it is unnecessary to be chosen for treating the pregnant cases with severe p(H1N1) infection.
Median time of admission to hospital in the death group was 4 days after the onset and in the surviving group was 2 days.
cNine patients in the non-surviving group and seven in the surviving group received noradrenaline.
As shown in Figure 7, the serum levels of FOXO1, ACVR2A and IHH in the surviving group were significantly higher than those in the non-surviving group at all time points (P<0.001).
Different from sTREM-1 levels, CRP and PCT levels in the surviving group were lower than those in the non-surviving group, indicating that patients with higher expressions of CRP and PCT may have poorer prognoses (although CRP and PCT levels tended to decrease in both groups over time).
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com